An MR analysis using common variants in the HMGCR gene that encodes HMG-CoA reductase – the intended target of statins – demonstrated that the same variant that associated with lower LDL-C also caused higher T2DM risk, higher plasma insulin and glucose, and higher body weight and BMI [46]. Here, INS is linked to type 2 diabetes mellitus.